SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings and future AI revenue projections, Broadcom is trending down, sparking community discussion around potential margin compression and customer concentration concerns. The community is debating whether this dip is a buying opportunity or the start of a broader tech sector correction, with some pointing to analyst upgrades as a bullish signal while others express caution about AI valuations.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed speculation around a past AI server deal and its low float after a reverse split, leading to community discussions about a potential short squeeze. Some traders are comparing it to other low-float runners and anticipating a significant price surge, while noting the stock's recent volatility and potential for both gains and losses. Community members highlight the stock's bullish technical setup and discuss strategies for maximizing potential profits, with many expressing optimism about its prospects.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain ($ARBK) is trending due to its reverse stock split and significant price drop, sparking discussions around short squeeze opportunities. The community is focused on its volatility and potential as a low float runner, while acknowledging its recent restructuring and London Stock Exchange delisting. Traders are weighing the risks and potential rewards amid the company's efforts to avoid insolvency.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending downwards following news of a UK class action lawsuit concerning talc-related cancer claims, sparking a sell-off despite the company's denial of the allegations. The community is debating whether the market's reaction is an overcorrection and potential buying opportunity, with some citing the company's strong fundamentals and oversold conditions. Some investors are drawing comparisons to Johnson & Johnson's past talc litigation and expressing concerns over potential long-term legal liabilities.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is gaining traction as a potential leader in the Ethereum meme space, with the community rallying behind the narrative of a long-awaited prophecy alongside Doge and Pepe. Discussions highlight strong community support, steady chart momentum, and the potential for significant growth, positioning $YEE as a key player in the 'Wall Street ETH season'.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending following a large verdict in a talc-related cancer case, raising concerns about ongoing legal liabilities and potential impacts on the company and its spin-off, Kenvue.  Community discussions center on the potential for further lawsuits, the company's handling of the situation, and whether J&J can maintain its growth trajectory amidst these challenges.  Despite legal headwinds, analysts note the company's diversified healthcare portfolio offers a degree of stability.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is gaining attention as investors discuss its potential for a Santa rally and long-term growth, with some community members projecting significant price increases. Discussions also involve comparisons to other cryptocurrencies, particularly Keeta, focusing on transaction speeds and institutional financial applications. Community members are closely monitoring chart patterns and potential breakout points, hoping for a sustained upward trend.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending due to its removal from the Nasdaq 100, triggering fund selling and tax-loss harvesting, though some view this as a buying opportunity amid strong fundamentals. Community discussions revolve around the impact of insider selling and the potential for a turnaround, especially with a recently approved buyback program. Despite the negativity, some traders are optimistic about a potential "January effect" and long-term growth in the connected TV ad space.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to community excitement around potential news and a possible buyout, fueled by the repeated use of "brownies" as a meme within investor discussions. Speculation is rising that this reflects excitement for potential partnerships in light of a strong safety profile. The community is closely watching for any upcoming news catalysts that could significantly impact the stock's valuation.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BCTX is trending due to recent presentation of Phase 2 survival and Phase 3 clinical data at SABCS, highlighting promising results for its Bria-IMT regimen in metastatic breast cancer, although some investors express concerns about dilution and the company's history of offerings. The community is actively debating the potential for a breakthrough in cancer treatment versus skepticism regarding the company's financials and management. Discussions also include the company's cash runway and potential for a buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KPTI Bankruptcy early 2026:

“ Taking into account the repayment of the 2025 Notes and the minimum liquidity covenant, Karyopharm expects its cash, cash equivalents and investments will be sufficient to fund its operations into the fourth quarter of 2025.”

They can do a little monster financing once more 2 delay 2 Q’s, but then it is game-over. Bankruptcy and assets being stripped off by highest bidder…inevitable

StockTwits for iOS

Karyopharm Therapeutics Inc

 Bankruptcy early 2026:

“ Taking into account the repayment of the 2025 Notes and the minimum liquidity covenant, Karyopharm expects its cash, cash equivalents and investments will be sufficient to fund its operations into the fourth quarter of 2025.”

They can do a little monster financing once more 2 delay 2 Q’s, but then it is game-over. Bankruptcy and assets being stripped off by highest bidder…inevitable

elmono

15-20 million cash burn per Q. 2 Q’s of financing equals current cap….anybody can do the math. Need to cut cost immediately by 50 million annually to stand a chance….meaning drastic measures

@elmono I posted a response about if Ph3 MF hits, what would be the valuation ($1b?) and stock price to reflect that after further dilution after data to take care of the debt - I am coming up with SP 15-20.

StockTwits Web

 I posted a response about if Ph3 MF hits, what would be the valuation ($1b?) and stock price to reflect that after further dilution after data to take care of the debt - I am coming up with SP 15-20.

Bamin

@Bamin they won’t get to that point before bankruptcy…..or imagine 200 million shares issued @ 1 usd average….so assume 200 million shares ex warrants. Assume 70% BO after approval in 2028-2029. Need to consider 50-70% BO premium…tell me how it’ll trade the next 2 yrs

 they won’t get to that point before bankruptcy…..or imagine 200 million shares issued @ 1 usd average….so assume 200 million shares ex warrants. Assume 70% BO after approval in 2028-2029. Need to consider 50-70% BO premium…tell me how it’ll trade the next 2 yrs

@elmono Surely they will extend the payment for 1-2 months to get to Ph3 MF data.  IF data hits both co-1EPs, then this is a 1B dollar enterprise value company.  They will raise at $15 or whatever (this is what I am not sure would be the correct price to reflect the value) to cover the immediate debt and the rest is due 2028.    They are not going to declare bankruptcy when the data could result in a 1B+ valuation and BO and is 1 month past 15Oct due date - they will find a way to delay the 24.5m payment.

 Surely they will extend the payment for 1-2 months to get to Ph3 MF data.  IF data hits both co-1EPs, then this is a 1B dollar enterprise value company.  They will raise at $15 or whatever (this is what I am not sure would be the correct price to reflect the value) to cover the immediate debt and the rest is due 2028.    They are not going to declare bankruptcy when the data could result in a 1B+ valuation and BO and is 1 month past 15Oct due date - they will find a way to delay the 24.5m payment.

@Bamin We will see I guess…….it’ll all depend how much they dilute and how much this is driven down before…it’ll also depend of course on the p3 results and whether they’ll be delayed or not. if p3 misses, it is basically game over, despite having a product in the market.

 We will see I guess…….it’ll all depend how much they dilute and how much this is driven down before…it’ll also depend of course on the p3 results and whether they’ll be delayed or not. if p3 misses, it is basically game over, despite having a product in the market.

@elmono Yes. Agree.  Only thing is maybe the dilute or maybe they do not to extend runway - maybe they work something out to delay that first debt payment til data release via a sweeter deal, not sure how it will work.  Also, maybe they get a contingent deal in place before then, or some other exotic partnership, you never know.

 Yes. Agree.  Only thing is maybe the dilute or maybe they do not to extend runway - maybe they work something out to delay that first debt payment til data release via a sweeter deal, not sure how it will work.  Also, maybe they get a contingent deal in place before then, or some other exotic partnership, you never know.

@Bamin you don’t…but with a small market cap you are not in a position to get bargain deals before a pivotal read out and on the verge of bankruptcy….you don’t hold the cards as our orange baboon would say…

 you don’t…but with a small market cap you are not in a position to get bargain deals before a pivotal read out and on the verge of bankruptcy….you don’t hold the cards as our orange baboon would say…

@elmono understand.... hopefully we get an answer with May earnings

 understand.... hopefully we get an answer with May earnings